---
figid: PMC3226315__AH2012-308252.001
figlink: /pmc/articles/PMC3226315/figure/fig1/
number: Figure 1
caption: The recent focus in JMML has concentrated on using the information gained
  from knowledge of these molecular defects in order to design targeted drug therapy.
  Animal models, especially mouse models of the disease, are commonly used to test
  molecularly targeted agents. Since RAS hyperactivation is very important in the
  pathophysiology of JMML, agents designed to decrease RAS activity are being evaluated.
  There are numerous approaches that have been tested to target this pathway ().
pmcid: PMC3226315
papertitle: Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia.
reftext: Xiaoling Liu, et al. Adv Hematol. 2012;2012:308252.
pmc_ranked_result_index: '17514'
pathway_score: 0.9570993
filename: AH2012-308252.001.jpg
figtitle: Recent focus in JMML has concentrated on using the information gained from
  knowledge of these molecular defects in order to design targeted drug therapy
year: '2012'
organisms: Homo sapiens
ndex: 38105467-dee6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3226315__AH2012-308252.001.html
  '@type': Dataset
  description: The recent focus in JMML has concentrated on using the information
    gained from knowledge of these molecular defects in order to design targeted drug
    therapy. Animal models, especially mouse models of the disease, are commonly used
    to test molecularly targeted agents. Since RAS hyperactivation is very important
    in the pathophysiology of JMML, agents designed to decrease RAS activity are being
    evaluated. There are numerous approaches that have been tested to target this
    pathway ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT5B
  - SOS2
  - RORC
  - PTPN11
  - SOS1
  - PIK3CA
  - AKT1
  - STAT5A
  - AKT2
  - PIK3R5
  - PIK3R3
  - PIK3R4
  - AKT3
  - PIK3R6
  - NF1
  - MAPK1
  - SHC3
  - PIK3CD
  - MAPK3
  - SHC4
  - NRAS
  - PIK3CB
  - SHC1
  - KRAS
  - HRAS
  - MAP2K1
  - MAP2K2
  - SHC2
  - PIK3CG
  - GRB2
  - JAK2
  - CSF2
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: Ras-GDP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: Ras-GDP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras-GDP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: GM-CSF
  symbol: GM-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF2
  entrez: '1437'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
